BioCardia BCDA
NASDAQ BCDA
$1.04 +0.02 (+1.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012)

Updated

BioCardia (BCDA) reported Income from Discontinued Operations of $636,000 for Q4 2012, down 94.6% from $11.71 million a year earlier.

Analysis

BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012) Analysis & Trends

Dating back to Q3 2010, BioCardia's Income from Discontinued Operations record includes 7 quarters.

  • By year, Income from Discontinued Operations came in at $10.29 million in FY2011 and -$10.95 million in FY2010.
  • The Q4 2012 figure ranks as the lowest quarterly Income from Discontinued Operations since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 BioCardia 12.58 Mn -287,001.74 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 636,000.00
Dec 31, 2011 11.71 Mn
Sep 30, 2011 -52,000.00
Jun 30, 2011 -1.17 Mn
Mar 31, 2011 -196,000.00
Dec 31, 2010 -330,000.00
Sep 30, 2010 -8.01 Mn
API Access

BioCardia Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=BCDA&period=max&api_key=YOUR_API_KEY